Australia / Northern Territory territory guide

Peptides in Northern Territory: check the ARTG and local supply record.

A Northern Territory-specific peptide guide connecting national TGA product records and practitioner registration to Northern Territory Health's official territory route for pharmacy, premises, or medicines-supply claims.

Market brief

What changes in Northern Territory.

In Northern Territory, an Australian domain, local address, clinic page, pharmacy name, or delivery promise does not establish that a peptide product is included in the ARTG or that its supply route is supported. Northern Territory Health provides the territory route for pharmacy premises, scheduled-substance supply, licences, registrations, and authorisations.

  • Northern Territory Health provides the territory route for pharmacy premises, scheduled-substance supply, licences, registrations, and authorisations; use the current official route instead of a badge, screenshot, local phone number, or seller-supplied credential alone.
  • The TGA states that a research-use disclaimer does not by itself make import, manufacture, advertising, compounding, or supply of an unapproved peptide product lawful.
  • Peptide Local does not publish a Northern Territory seller ranking until product category, national record, local authority route, Australian delivery, exact price, and observation date are sourced together.
Verification route

Know which record answers which question.

Local checklist

Three checks before any comparison.

Use this checklist to verify the local product, seller, and supply records before comparing price or availability.

01

Resolve the territory record

Open medicines and poisons and match the legal business, premises, licence, registration, or supply category behind an offer involving Northern Territory.

02

Check the exact product nationally

Search the ARTG for the product, sponsor, active ingredient, dosage form, and identifier. If no record resolves, identify the exact exemption or access pathway instead of treating a shared name as authorization.

03

Keep the supply category attached

Separate prescription medicines, pharmacy services, compounded preparations, personal imports, clinical programs, and research-labelled materials before comparing any price or availability claim.

Direct answers

What this guide can - and cannot - answer.

Each answer is tied to the local records below so you can see what is confirmed, what remains unknown, and where to recheck it. Open the primary sources ↓

01

Can every peptide offer be treated as legal to buy in Northern Territory?

No blanket answer is supportable. Open medicines and poisons and match the legal business, premises, licence, registration, or supply category behind an offer involving Northern Territory. In Northern Territory, begin with Medicines and poisons from Northern Territory Health; the product, seller, and supply route still need to resolve to the same current record.

02

Does this page name the best place to buy peptides in Northern Territory?

No. Peptide Local withholds a commercial table for Northern Territory until seller category, local delivery, regulatory or research status, exact price, and observation date are all sourced. This page is a verification route, not a shopping recommendation.

03

Which official records should I check first in Northern Territory?

For Northern Territory, start with Medicines and poisons from Northern Territory Health, then open Searching the Australian Register of Therapeutic Goods from Therapeutic Goods Administration. The records answer separate questions, so confirm each current entry instead of treating one match as proof of the seller, product, and route together.

Compound and jurisdiction routes

Tracked peptide names in Northern Territory.

Each answer preserves the compound’s research, clinical, or medicine identity, connects it to the ARTG and practitioner register when relevant, and then points to the official Northern Territory route. A shared name or local record is not a blanket product, seller, legal, or availability finding.

01FDA-reviewed unapproved peptide identity

KPV in Northern Territory

KPV in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
02US research-market identity

BPC-157 in Northern Territory

BPC-157 in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
03US research-market identity

TB-500 in Northern Territory

TB-500 in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
04US research-market identity

GHK-Cu in Northern Territory

GHK-Cu in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
05US research-market identity

Semax in Northern Territory

Semax in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
06US research-market identity

Melanotan II in Northern Territory

Melanotan II in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
07US research-market identity

MOTS-c in Northern Territory

MOTS-c in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
08US research-market identity with a separate FDA-licensed medicine record

Tesamorelin in Northern Territory

Tesamorelin in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
09US research-market identity with a failed oral obesity program and no FDA-approved drug

AOD-9604 in Northern Territory

AOD-9604 in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
10US research-market identity

Ipamorelin in Northern Territory

Ipamorelin in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
11US research-market identity

Selank in Northern Territory

Selank in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
12US research-market identity with a separate FDA-approved medicine record

PT-141 / Bremelanotide in Northern Territory

PT-141 / Bremelanotide in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
13US research-market identity

CJC-1295 no DAC in Northern Territory

CJC-1295 no DAC in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
14US research-market identity

CJC-1295 DAC in Northern Territory

CJC-1295 DAC in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
15Investigational clinical program

Retatrutide in Northern Territory

Retatrutide in Northern Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
16China-approved medicine and active clinical program

Mazdutide in Northern Territory

Mazdutide in Northern Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
17China-approved medicine and active development program

Ecnoglutide in Northern Territory

Ecnoglutide in Northern Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
18Investigational clinical program

Enicepatide in Northern Territory

Enicepatide in Northern Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
19Investigational clinical program

Eloralintide in Northern Territory

Eloralintide in Northern Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
20Investigational clinical program

Cagrilintide in Northern Territory

Cagrilintide in Northern Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
21Investigational clinical program

Petrelintide in Northern Territory

Petrelintide in Northern Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
22Investigational clinical program

CagriSema in Northern Territory

CagriSema in Northern Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
23Investigational clinical program

MariTide in Northern Territory

MariTide in Northern Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
24Investigational clinical program

Survodutide in Northern Territory

Survodutide in Northern Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
25Investigational clinical program

VK2735 in Northern Territory

VK2735 in Northern Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
26Investigational clinical program

Pemvidutide in Northern Territory

Pemvidutide in Northern Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
27Investigational clinical program

Amycretin / Zenagamtide in Northern Territory

Amycretin / Zenagamtide in Northern Territory refers first to an investigational clinical program, not an approved Australian product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, manufacturing controls, or regulatory status. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
28US FDA medicine reference

Tirzepatide in Northern Territory

Tirzepatide in Northern Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
29FDA-approved US medicine with country-specific status elsewhere

Orforglipron / Foundayo in Northern Territory

Orforglipron / Foundayo in Northern Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
30Product-specific approved medicine records in multiple jurisdictions

Semaglutide in Northern Territory

Semaglutide in Northern Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
31FDA-flagged unapproved research-market peptide identity

DSIP / Emideltide in Northern Territory

DSIP / Emideltide in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
32US research-market identity

IGF-1 LR3 in Northern Territory

IGF-1 LR3 in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
33US research-market identity

Kisspeptin-10 / KP-10 in Northern Territory

Kisspeptin-10 / KP-10 in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
34US research-market identity separated from SCENESSE

Melanotan I in Northern Territory

Melanotan I in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
35US research-market non-peptide coenzyme identity

NAD+ in Northern Territory

NAD+ in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
36US research-market identity with a withdrawn historical medicine record

Sermorelin in Northern Territory

Sermorelin in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
37No FDA-approved US product; exact foreign prescription products exist

Thymosin Alpha-1 in Northern Territory

Thymosin Alpha-1 in Northern Territory begins with a research-market identity, not a finding that a same-name product is included in the ARTG, lawfully supplied, locally available, independently tested, or appropriate for use in Australia. A research-use disclaimer cannot resolve those questions by itself. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
38FDA-approved US medicine with a withdrawn EU application

EGRIFTA WR in Northern Territory

EGRIFTA WR in Northern Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
39Product-specific FDA and EU medicine records

Liraglutide in Northern Territory

Liraglutide in Northern Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
40Product-specific FDA and EU medicine records

SCENESSE in Northern Territory

SCENESSE in Northern Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
41Product-specific FDA-approved US medicine record

VYLEESI in Northern Territory

VYLEESI in Northern Territory begins with a medicine identity, but Australian authorization belongs to an exact therapeutic good, sponsor, presentation, route, ARTG record, and regulated supply path. A shared ingredient or brand reference does not transfer that record to every listing. For a pharmacy, clinic, practitioner, importer, or seller claim involving Northern Territory, open Medicines and poisons from Northern Territory Health and match the business, premises, licence, registration, supply category, and current status. Then search the exact product and sponsor separately in the Australian Register of Therapeutic Goods and check the practitioner in Ahpra when relevant. A local record does not authorize a product, and an ARTG record does not validate a different seller, parcel, or service.

Official jurisdiction routeMedicines and poisonsNorthern Territory Health
00
Publishing gate

No commercial price table yet.

Peptide Local will not manufacture a ranking from thin data. A local table appears only after seller category, authorization or research status, delivery market, price, and source date can all be stated clearly.

Primary sources

Repeat the checks yourself.

Official sources are linked directly. Open them to confirm the current record; this page is a guide, not a substitute for the regulator.

Related guides